Phase IIa trial assessing the efficacy and safety of Enpatoran in patients with dermatomyositis and polymyositis: NEPTUNIA rationale and study design

被引：0
|
作者：
Aggarwal, R. [1 ]
Roy, S. [2 ]
Thommes, G. [3 ]
Weinelt, D. [3 ]
Chitkara, D. [4 ]
Denis, D. [5 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Ares Trading SA, Affiliate Merck KGaA, Eysins, Switzerland
[3] Merck Healthcare KGaA, Darmstadt, Germany
[4] EMD Serono Res & Dev Inst Inc, Affiliate Merck KGaA, Billerica, MA USA
[5] EMD Serono Inc, Affiliate Merck KGaA, Rockland, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2024年 / 43卷
关键词：
D O I：
10.1016/j.nmd.2024.07.393
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
683P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety of a home exercise programme in patients with polymyositis and dermatomyositis:: a pilot study
    Alexanderson, H
    Stenström, CH
    Lundberg, I
    RHEUMATOLOGY, 1999, 38 (07) : 608 - 611
  • [2] EFFICACY AND SAFETY OF LENABASUM IN THE PHASE 3 DETERMINE TRIAL IN DERMATOMYOSITIS
    Werth, V.
    White, B.
    Dgetluck, N.
    Hally, K.
    Constantine, S.
    Aggarwal, R.
    Fiorentino, D.
    Lundberg, I. E.
    Oddis, C. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 106 - 107
  • [3] Safety and efficacy of patupilone in patients with advanced breast cancer: a phase IIa trial.
    Toppnieyer, D. L.
    Mackey, J.
    Sessa, C.
    Johriar, A. R.
    Kaufman, P. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S73 - S74
  • [4] The efficacy and safety of tacrolimus in patients with dermatomyositis/polymyositis: A meta-analysis and systematic review
    Liao, Jiafen
    Peng, Xiaofei
    Liu, Jiayi
    Xie, Xi
    Wang, Jia
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 110 : 35 - 40
  • [5] Enpatoran in COVID-19 pneumonia: Safety and efficacy results from a phase II randomized trial
    Mckinnon, John E.
    Santiaguel, Joel
    de Oliveira, Claudia Murta
    Yu, Dongzi
    Khursheed, Mukhy
    Moreau, Flavie
    Klopp-Schulze, Lena
    Shaw, Jamie
    Roy, Sanjeev
    Kao, Amy H.
    ANEMONE Study Team
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (12): : 2640 - 2653
  • [6] EVALUATING EFFICACY AND SAFETY OF A 10% INTRAVENOUS IMMUNOGLOBULIN SOLUTION IN PATIENTS WITH DERMATOMYOSITIS (PRODERM STUDY) - DESIGN OF A PHASE III STUDY
    Aggarwal, R.
    Charles-Schoeman, C.
    Schessl, J.
    Levine, T.
    MUSCLE & NERVE, 2017, 56 : S10 - S10
  • [7] Safety, tolerability, pharmacokinetics, and efficacy of kukoamine B in patients with sepsis: A randomized phase IIa trial
    Hu, Xiao-Yun
    Zhang, Weiwen
    Wang, Difen
    Sun, Yunbo
    Hu, Zhenjie
    Zang, Bin
    Feng, Yongwen
    Wang, Huaxue
    Zhou, Jianxin
    Zhao, Qian
    Liu, Hongzhong
    Wang, Teng
    Jiang, Wei
    Wang, Chun-Yao
    Jin, Chunyan
    Dong, Kai
    Chen, Shuai
    Yao, Xiaoqing
    Hu, Pei
    Du, Bin
    JOURNAL OF CRITICAL CARE, 2023, 76
  • [8] Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial
    Lorenzatti, Alberto J.
    Eliaschewitz, Freddy G.
    Chen, Yundai
    Fialkow, Jonathan
    Lu, Juming
    Baass, Alexis
    Monsalvo, Maria Laura
    Hsu, Hui-Chun
    Somaratne, Ransi
    Ge, Junbo
    CLINICAL CARDIOLOGY, 2018, 41 (09) : 1117 - 1122
  • [9] Safety and Efficacy Data from a Phase I Trial of Umbilical Lining-Derived Stem Cells (ULSC) in Adult Dermatomyositis/Polymyositis
    Bubb, Michael R.
    Handberg, Eileen
    Gonzalez, Rafael
    Betancourt, Blas
    Bostick, J. Nicole
    Long, Sarah
    March, Keith
    Pepine, Carl
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3539 - 3541
  • [10] The Phase III CONNEX programme assessing the efficacy and safety of iclepertin in patients with schizophrenia: Trial design and recruitment update
    Reuteman-Fowler, C.
    Blahova, Z.
    Ikezawa, S.
    Marder, S.
    Falkai, P.
    Krystal, J. H.
    EUROPEAN PSYCHIATRY, 2024, 67 : S87 - S88
12345